Jommi, C., Fanelli, F., Pedone, M., Cipriani, F., & Canonica, G. (2020). PRS24 The CROSS-Coverage Effect of Dupilumab in Treating Coexisting Type 2 Inflammatory Diseases on the Italian National Health Service Expenditure. Value in health, 23, S720-S721. https://doi.org/10.1016/j.jval.2020.08.1904
Chicago-Zitierstil (17. Ausg.)Jommi, C., F. Fanelli, M.P Pedone, F. Cipriani, und G.W Canonica. "PRS24 The CROSS-Coverage Effect of Dupilumab in Treating Coexisting Type 2 Inflammatory Diseases on the Italian National Health Service Expenditure." Value in Health 23 (2020): S720-S721. https://doi.org/10.1016/j.jval.2020.08.1904.
MLA-Zitierstil (9. Ausg.)Jommi, C., et al. "PRS24 The CROSS-Coverage Effect of Dupilumab in Treating Coexisting Type 2 Inflammatory Diseases on the Italian National Health Service Expenditure." Value in Health, vol. 23, 2020, pp. S720-S721, https://doi.org/10.1016/j.jval.2020.08.1904.